 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction / Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products / Modifiers / Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
 Dental and Oral Agents
|
Amlexanox
|
Cevimeline
|
Chlorhexidine
|
Doxycycline
|
Minocycline
|
Palifermin
|
Pilocarpine
|
 D00525 Pilocarpine (JAN/USP)
D08376 Pilocarpine borate
D02200 Pilocarpine hydrochloride (JP16/USP)
D05478 Pilocarpine nitrate (USP)
|
Prilocaine
|
Triamcinolone
|
|
Dermatological Agents
|
|
Enzyme Replacement / Modifying Agents
|
|
Gastrointestinal Agents
|
|
Genitourinary Agents
|
|
Hormonal Agents
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
Ophthalmic Anti-allergy Agents
|
Ophthalmic Antiglaucoma Agents
|
Alpha-2 Adrenergic Agonists, Ophthalmic
|
Beta-Adrenergic Blocking Agents, Ophthalmic
|
Carbonic Anhydrase Inhibitors, Ophthalmic
|
Cholinergic Agonists, Ophthalmic
|
Echothiophate
|
Pilocarpine
|
D00525 Pilocarpine (JAN/USP)
D08376 Pilocarpine borate
D02200 Pilocarpine hydrochloride (JP16/USP)
D05478 Pilocarpine nitrate (USP)
|
Ophthalmic Anti-inflammatories
|
Ophthalmic Prostaglandin and Prostamide Analogs
|
Ophthalmic Agents, Other
|
|
Otic Agents
|
|
Respiratory Tract Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
|
Therapeutic Nutrients / Minerals / Electrolytes
|
USP Drug Classification